← Leaderboards
Patricia J Giardina
Weill Medical College Of Cornell Univ
$4,084,595
Attributed
$4,084,595
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $446.2K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,955,434 · 8
CDC$1,129,161 · 2
By mechanism
U01$3,162,941 · 2
M01$698,743 · 7
U27$222,911 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Stefano Rivella$10,978,618
- Robert W. Grady$4,332,176
- Ronald G Crystal$80,684,359
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman Therapy EvaluationHuman SubjectThalassemiaClinical TrialsDeferoxamineDrug Screening /EvaluationIron MetabolismPatient /Disease RegistryChelation TherapyMedical ComplicationAntineoplasticsBlood TransfusionBone MetabolismMetabolism Disorder ChemotherapyImmunotherapyAntiinflammatory AgentsInterferonsMicroorganism Disease ChemotherapyHepatitis CCooperative StudyCombination TherapyIron DisorderOsteoporosis
Grant awards (33)
Prevention of Complications of Thalassemia$150,000
U01 · FY2011 · DD · contact PI
Prevention of Complications of Thalassemia$150,000
U01 · FY2010 · DD · contact PI
Prevention of Complications of Thalassemia$200,000
U01 · FY2009 · DD · contact PI
Thalassemia Clinical Research Network$105,341
U01 · FY2009 · HL · contact PI
Prevention of Complications of Thalassemia$200,000
U01 · FY2008 · DD · contact PI
Thalassemia Clinical Research Network$105,340
U01 · FY2008 · HL · contact PI
Prevention of Complications of Thalassemia$206,250
U01 · FY2007 · DD · contact PI
Thalassemia Clinical Research Network$105,338
U01 · FY2007 · HL · contact PI
DESFERRIOXAMINE THERAPY IN IRON OVERLOAD$3,102
M01 · FY2007 · RR · contact PI
PREVENTION OF THE COMPLICATIONS OF THALASSEMIA$222,911
U27 · FY2006 · DD · contact PI
DESFERRIOXAMINE THERAPY IN IRON OVERLOAD$81,024
M01 · FY2006 · RR · contact PI
Thalassemia Clinical Research Network$1
U01 · FY2006 · HL · contact PI
Thalassemia Clinical Research Network$215,874
U01 · FY2005 · HL
DESFERRIOXAMINE THERAPY IN IRON OVERLOAD$209,163
M01 · FY2005 · RR
THALASSEMIA CLINICAL RESEARCH NETWORK CROSS-SECTIONAL STUDY OF OSTEOPOROSIS$21,136
M01 · FY2005 · RR
PREVENTION OF THE COMPLICATIONS OF THALASSEMIA$0
U27 · FY2005 · DD
NEW YORK REGION THALASSEMIA CENTER$344,200
U01 · FY2004 · HL
PREVENTION OF THE COMPLICATIONS OF THALASSEMIA$0
U27 · FY2004 · DD
NEW YORK REGION THALASSEMIA CENTER$360,600
U01 · FY2003 · HL
PREVENTION OF THE COMPLICATIONS OF THALASSEMIA$0
U27 · FY2003 · DD
NEW YORK REGION THALASSEMIA CENTER$350,097
U01 · FY2002 · HL
DMHP(DEFERIPRONE)--AN ORAL IRON CHELATION AGENT FOR THALASSEMIA$0
M01 · FY2002 · RR
DESFERRIOXAMINE THERAPY IN IRON OVERLOAD$0
M01 · FY2002 · RR
A COMPREHENSIVE STUDY OF CLINICALLY STAGED PEDIATRIC HODGKIN'S DISEASE$0
M01 · FY2002 · RR
PREVENTION OF THE COMPLICATIONS OF THALASSEMIA$0
U27 · FY2002 · DD
NEW YORK REGION THALASSEMIA CENTER$339,900
U01 · FY2001 · HL
DESFERRIOXAMINE THERAPY IN IRON OVERLOAD$0
M01 · FY2001 · RR
A COMPREHENSIVE STUDY OF CLINICALLY STAGED PEDIATRIC HODGKIN'S DISEASE$0
M01 · FY2001 · RR
DMHP(DEFERIPRONE)--AN ORAL IRON CHELATION AGENT FOR THALASSEMIA$0
M01 · FY2001 · RR
NEW YORK REGION THALASSEMIA CENTER$330,000
U01 · FY2000 · HL
A COMPREHENSIVE STUDY OF CLINICALLY STAGED PEDIATRIC HODGKIN'S DISEASE$128,106
M01 · FY2000 · RR
DESFERRIOXAMINE THERAPY IN IRON OVERLOAD$128,106
M01 · FY2000 · RR
DMHP(DEFERIPRONE)--AN ORAL IRON CHELATION AGENT FOR THALASSEMIA$128,106
M01 · FY2000 · RR